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Background: Type 1 diabetes is associated with raised inflammation, impaired endothelial progenitor cell mobilisation
and increased markers of vascular injury. Both acute and chronic exercise is known to influence these markers in
non-diabetic controls, but limited data exists in Type 1 diabetes. We assessed inflammation, vascular repair and injury
at rest and after exercise in physically-fit males with and without Type 1 diabetes.
Methods: Ten well-controlled type 1 diabetes (27 ± 2 years; BMI 24 ± 0.7 kg.m2; HbA1c 53.3 ± 2.4 mmol/mol) and nine
non-diabetic control males (27 ± 1 years; BMI 23 ± 0.8 kg.m2) matched for age, BMI and fitness completed 45-min of
running. Venous blood samples were collected 60-min before and 60-min after exercise, and again on the following
morning. Blood samples were processed for TNF-α using ELISA, and circulating endothelial progenitor cells (cEPCs;
CD45dimCD34+VEGFR2+) and endothelial cells (cECs; CD45dimCD133-CD34+CD144+) counts using flow-cytometry.
Results: TNF-α concentrations were 4-fold higher at all-time points in Type 1 diabetes, when compared with control
(P < 0.001). Resting cEPCs were similar between groups; after exercise there was a significant increase in controls
(P = 0.016), but not in Type 1 diabetes (P = 0.202). CEPCs peaked the morning after exercise, with a greater change in
controls vs. Type 1 diabetes (+139 % vs. 27 %; P = 0.01). CECs did not change with exercise and were similar between
groups at all points (P > 0.05). Within the Type 1 diabetes group, the delta change in cEPCS from rest to the following
morning was related to HbA1c (r = -0.65, P = 0.021) and TNF-α (r = -0.766, P = 0.005).
Conclusions: Resting cEPCs and cECs in Type 1 diabetes patients with excellent HbA1c and high physical-fitness are
comparable to healthy controls, despite eliciting 4-fold greater TNF-α. Furthermore, Type 1 diabetes patients appear to
have a blunted post-exercise cEPCs response (vascular repair), whilst a biomarker of vascular injury (cECs) remained
comparable to healthy controls.
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Table 1 Type 1 diabetes and control group participant
characteristics mean ± SEM
T1DM CON P value
Age (years) 27 ± 2 27 ± 1 =0.798
BMI (kg.m2) 24 ± 0.7 23 ± 0.8 =0.243
VO2max (ml.kg.min
-1) 51.0 ± 2.1 50.7 ± 1.1 =0.808
HbA1c (mmol/mol / %) 53.3 ± 2.4 /6.9 ± 0.2 % — —
Diabetes duration (years) 12 ± 2.0 — —
P calculated from independent samples t-test
BMI Body Mass Index, VO2max aerobic capacity
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Exercise carries many health benefits for people with Type
1 diabetes [1]. Of particular importance, regular physical
exercise is associated with improvements in an array of
cardiovascular risk factors such as cardiorespiratory fit-
ness, endothelial function, and blood lipid profiles. These
benefits are of significance given the raised cardiovascular
risk and early mortality in these patients [2].
Exposure to hyperglycaemia and chronic inflammation
ultimately means that individuals with Type 1 diabetes
demonstrate raised markers of vascular damage, such as
circulating endothelial cells (cECs; [3]), and endothelial
dysfunction [4], in comparison with healthy controls [4,
3]. Accompanying this may be a reduction in circulating
endothelial progenitor cell count (cEPCs; [4, 5]); bone
marrow derived cEPCs are highly important for vascular
repair and protection [5, 6] and are a significant pre-
dictor of endothelial function [4, 7] and cardiovascular
risk [7].
A single exercise bout has been shown to acutely raise
cEPCs count in both healthy and patient populations [8–
11]. For example, Rehman et al [8] demonstrated that a
single bout of cycling exercise significantly raised cEPCs
by ~4 fold after exercise, in sedentary over weight males.
Similar increases in cEPCs after exercise have been dem-
onstrated in healthy, physically fit individuals, as well as in
sedentary individuals with chronic disease [9]. However,
data on the acute cEPCs response to exercise within Type
1 diabetes is lacking. Regular exercise training is associ-
ated with raised resting cEPCs and has a strong anti-
inflammatory effect [12, 13]. Indeed, these benefits are
likely integral to the cardio-protective role regular exercise
provides. With this in mind, and the association of Type 1
diabetes with reduced cEPCs and raised inflammation, it
is of scientific importance to determine the acute cEPCs
response to exercise within Type 1 diabetes patients.
Moreover, how the resting cEPCs, cECs and inflamma-
tory status of physically fit type 1 diabetes patients com-
pares to matched, non-diabetic controls would also be of
interest. Physical fitness is a measure that is not considered
within the existing literature comparing cEPCs (marker of
vascular repair), cECs (marker of vascular damage) and in-
flammation in this population [4, 3]. Therefore, the aim of
this study was to assess the cEPCs, cECs and inflammation
at rest and in response to submaximal exercise in
physically-fit males with and without Type 1 diabetes.
Methods
Participants
Eligibility criteria for type 1 diabetes patients consisted of
being aged between 18 and 35 years, a duration of diabetes >
2 years, and an HbA1c < 8.0 % (64 mmol/mol). In addition,
patients were required to be free of all diabetes-related com-
plications including impaired awareness of hypoglycaemia(assessed via the Clarke method [14]) and not receiving any
medication other than insulin. Participants in both the Type
1 diabetes and control group had to be regularly and con-
sistently undertaking exercise (participating in aerobic based
exercise for a minimum of 30 min at a time, at least three
times per week, for > 12 months). Smokers were excluded
from both groups. Ten males with type 1 diabetes and nine
non-diabetic male controls, matched for age, anthropom-
etry, and fitness were recruited for this study (Table 1). Pa-
tients were treated with a basal-bolus regimen composed of
long-acting insulins glargine (n = 8) or detemir (n= 2), and
rapid-acting insulin aspart. All patients were stable on their
respective insulin regimen for a minimum of 1 year, and
were familiar with carbohydrate counting, administering 1.0
± 0.2 units of insulin aspart (IU) per 10 g of carbohydrate.Preliminary testing
Fully informed written consent was obtained from all
participants following the study’s approval from local
National Health Service Research Ethics Committee (13/
NE/0016). Type 1 diabetes participants attended the
Newcastle National Institute for Health Research Clin-
ical Research Facility exercise laboratory for a prelimin-
ary screening visit as described previously in detail [15],
before returning to establish peak cardio-respiratory pa-
rameters during the completion of an incremental-
maximal treadmill running protocol as per the methods
of Campbell et al [15], to determine the individual speed
participants would run at during the experimental trial.
The control group completed the same preliminary tests
at the Exercise Physiology laboratory at Northumbria
University.Experimental design
Type 1 diabetes patients were fitted with a real-time con-
tinuous glucose monitor (Paradigm Veo, Medtronic dia-
betes, Northridge, CA, USA) >24 h prior to the laboratory
visit with high and low alerts set to help maintain gly-
caemia within normal ranges prior to the experimental
session. Participants did not exercise within 96 h of the
experimental visit.
Fig. 1 Plasma TNF-α at rest, 60 min post-exercise, and on the morning
after exercise. Solid black bars = Control group, solid white bars = Type
1 diabetes group. * indicates a significant between group difference
(P < 0.05). Data presented as mean ± SEM
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with standardised cereal-based breakfast and pasta-based
lunch; prescribed by the research team. Participants ar-
rived to the laboratory at 17:00 h. Following a resting
blood sample participants consumed a pre-exercise carbo-
hydrate bolus (corn flakes, peaches, semi-skimmed milk;
1738 ± 71 kJ / 415 ± 17 kcal) equating to 1.0 g.carbohy-
drate.kg-1 body mass. With this meal, patients self-
administered a 25 % (2.0 ± 0.5 IU) dose (i.e. a 75 %
reduction [15–19]) of rapid-acting insulin into the ab-
domen. Following this bolus, participants remained
rested for 60 min, before commencing 45 min of tread-
mill running at a speed calculated to elicit 70 % of
VO2max. This exercise intensity falls within current rec-
ommendations of the American College of Sports Medi-
cine [20]. All participants completed the exercise
protocol and there were no hypoglycemic episodes
within the Type 1 diabetes group.
After exercise, participants remained at rest for 60 min
before a further blood sample was collected. Participants
were then discharged from the laboratory. On the fol-
lowing morning, participants returned to the laboratory
at 08:00 h for a further resting, fasted blood sample.
Blood sampling and data analysis
Venepuncture technique was used to collect 10 ml of
whole blood at each respective sample point. After dis-
carding the first four ml of collected blood, samples were
evenly dispersed into a K2EDTA and lithium heparin tube.
The lithium heparin tube was centrifuged for 15 min at
3000 rpm (4 °C) and stored at -80 °C for retrospective ana-
lysis of plasma Human TNF-α (Quantikine ELISA, R&D
Systems, Roche Diagnostics, West Sussex, UK). The
K2EDTA was sent for analysis of cEPCs and cECs imme-
diately and was processed within 2 h [21].
Circulating endothelial progenitor cells and circulating
endothelial cells
Flow cytometry
100 μl of whole blood was incubated with 5 μl of V500
CD45 (BD Biosciences, Oxford, UK), 20 μl of PerCP-Cy5.5
CD34 (BD Biosciences, Oxford, UK), 5 μl of PE VEGFR-2+
(R&D Systems, Roche Diagnostics, West Sussex, UK), 5 μl
APC CD133 (BD Biosciences, Oxford, UK), 10 μl FITC
CD144 (BD Biosciences, Oxford, UK) for 30 min. Subse-
quently, 2 ml of pharmlyse (BD Biosciences, Oxford, UK)
was used to lyse the red cells. The sample was then analysed
by flow cytometry on BD FACS Canto™ II system and sam-
ples were run to approximately 500,000 total events. Ana-
lysis was carried out using BD FACSDiva™ software. On
average 440,000 events were counted. CEPCs events were
defined using the most recent definition of CD45dimCD34+
VEGFR2 (KDR)+, as recommended by Van Craenenbroeck
et al. [21]. Intra-assay variation (CD45dimCD34+VEGFR-2+)was less than 8 %. The results were expressed as % leuko-
cytes [22, 21]. CECs events were defined as CD45dimCD133-
CD34+CD144+ [23, 24].Statistical analysis
Statistical analysis was performed using PASW Statistics
18 software (IBM, Armonk, NY) with significance set at
p ≤ 0.05. Plasma TNF-α responses were analysed using
mixed model ANOVA (group*time) and are presented
as mean ± SEM. CEPCs and CECs responses were
assessed using two-way Friedman’s analysis and are pre-
sented as median ± IQR. Between group differences, and
comparisons of the delta-change in cEPCs and cECs
counts, were assessed using Mann-Whitney U test. Rela-
tionships were assessed with Pearsons product moment
correlation coefficient or Spearman’s rank order correl-
ation coefficient.
Results
TNF-α
Plasma TNF-α responses are presented in Fig. 1. There
was no group*time interaction (P = 0.324), or change
over time (P = 0.103), however there was a significant ef-
fect of group (P < 0.001). The Type 1 diabetes group elic-
ited ~4 fold greater TNF-α concentrations at all sample
points, when compared to control (Fig. 1).
CEPCs & cECs
CEPCs counts are presented in Fig. 2a. Baseline cEPCs
counts were similar between groups (Fig. 2a). There was a
significant increase in cEPCs counts after exercise within
the control group (P = 0.016), however, there was no
change within the Type 1 diabetes patients (P = 0.202).
CEPCs counts peaked the morning after exercise within
the control group (Fig. 2a) and the delta change, from
Fig. 2 a Circulating endothelial progenitor cell (cEPC) counts at rest, 60 min post-exercise, and on the morning after exercise. Solid black bars = Control
group, solid white bars = Type 1 diabetes group. ≠ indicates within conditions difference to pre-exercise, # indicates within condition difference to
post-exercise (P < 0.05). b Change in cEPCs counts from rest to the morning after exercise. Solid black bars = Control group, solid white bars = Type 1
diabetes group. Data presented as median ± IQR
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trol group (Fig. 2b; P = 0.09). The median cEPCs count in-
creased by 139 % and 27 % in the control and type 1
diabetes groups, respectively (P = 0.01). CECs count re-
sponses are presented in Fig. 3. CECs count was similar at
all-time points between groups, and there was no signifi-
cant change in cECs with exercise within either Type 1
diabetes (P = 0.179) or control (P = 0.236) groups.
Relationships between variables
Within the Type 1 diabetes group, the delta change in
cEPCS from rest to the following morning was related
to HbA1c (r = -0.65, P = 0.021) and TNF-α (r = -0.766,
P = 0.005). There were no other significant relationshipsbetween cEPCs, cECs and TNF-α and participant char-
acteristics (VO2peak, BMI, age and duration of diabetes)
in either the control or Type 1 diabetes group.
Discussion
This study aimed to examine cEPCs, cECs and TNF-α at
rest, and in response to acute submaximal exercise, in
physically fit males with and without Type 1 diabetes.
This study is the first of this kind and we have shown
that resting cEPCs and cECs were similar between
groups, despite patients demonstrating ~4 fold greater
TNF-α concentrations. However, the increase in cEPCs
was blunted in the patients, with the change from rest to
the morning following exercise being ~112 % lower in
Fig. 3 Circulating endothelial cell (cECs) counts at rest, 60 min
post-exercise, and on the morning after exercise. Data presented as
median ± IQR
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Furthermore, our data showed that this blunted re-
sponse within the Type 1 diabetes group appeared to be
predicted by HbA1c and TNF-α concentrations.
Resting cEPCs and cECs
Our finding that resting cEPCs and cECs were similar be-
tween groups is in agreement with Fadini et al. [25], but
also contrasts with other literature in the area [4, 3]. In
comparison with Sibal et al. [4], the Type 1 diabetes pa-
tients of this study were of comparable age and had similar
duration of diabetes and also shared a raised inflammatory
state. The difference in the findings are potentially ex-
plained by the high cardio-respiratory fitness and excellent
glycemic control of our patients (HbA1c ~7 %, 53 mmol/
mol vs. ~8.5 %, 69.4 mmol/mol [4]). Indeed, the partici-
pants in the study of Fadini et al. [25] also had good HbA1c
(~7.7 %). Whilst the relationship between glycemic control
and cEPCs is established in Type 2 diabetes and acute myo-
cardial infarction [26, 27], there are few studies in Type 1
diabetes. Most recently it has been shown that in children
with Type 1 diabetes, cEPCs count was inversely related
with HbA1c [28]. In our study, it should be reassuring to
both patients and clinicians that after achieving good gly-
cemic control cEPCs were comparable to healthy controls.
However, since our patients were also very fit, it would be
interesting to investigate the change in HbA1c and cardio-
respiratory fitness both independently, and concomitantly
(e.g. via an exercise training programme), to provide further
insight into the normalised cEPCs we show.
cEPCs response to exercise
This is the first study to examine acute exercise and
cEPCs regulation in Type 1 diabetes and our findings sug-
gest that regulation of cEPCs release in response to an ex-
ercise stimulus may be abnormal despite eliciting normal
resting cEPCs and excellent glycemic control. Researchexamining the bone marrow biology of both animals and
patients with diabetes confirms that bone marrow func-
tion is impaired [29] which may reduce cEPCs mobilisa-
tion [25]. Recent research has shown that the mobilisation
of cEPCs in response to administration of recombinant
granulocyte colony-stimulating factor is impaired in dia-
betes patients [25]. Speculatively, bone marrow function
may also have contributed to the blunted cEPCs response
to exercise demonstrated in the Type 1 diabetes patients.
It is well established that resting cEPCs are normal or
high in active individuals [13, 9], thus it is of interest that
both groups of participants in our current study had a
cardio-respiratory fitness (VO2max 50 ml.kg.min
-1) which
would categorise them as excellent, or above average (aver-
age VO2max for males aged ~27 being ~ 42 ml.kg.min
-1
[20]). Earlier research has described ~4 fold higher cEPCs
in trained marathon runners when compared to sedentary
control participants [13], and there is evidence that regular
aerobic-exercise training is an effective intervention to raise
cEPCs in both healthy [13] and patient populations [9, 30].
Potentially, the regular aerobic exercise engaged in by the
participants in this study, evidenced by high cardio-
respiratory fitness, may additionally explain the comparable
resting cEPCs shown.
Inflammation and cEPCs
Our study provides another interesting finding that the
comparable cEPCs and cECs between groups were con-
comitant with ~4 fold higher TNF-α concentrations seen
in our Type 1 diabetes patients. The raised inflammation
is in agreement with our previous data of Sibal et al. [4].
There is evidence, in advanced cardiovascular disease pa-
tients, that cEPCs are reduced potentially due to the mye-
losuppressive effects of TNF-α [31]. Furthermore, three
months of TNF-α inhibitory drug treatment has been
shown to significantly raise cEPCs in rheumatoid arthritis
patients [32]. Further research is required to investigate
the interaction between the anti-inflammatory effects of
regular exercise in populations which experience chronic
inflammation, such as Type 1 diabetes.
We show for the first time that despite the excellent
glycemic control and high physical fitness of the Type 1
diabetes patients there was a blunting of the rise in
cEPCs elicited after exercise. Shear stress, increased ni-
tric oxide (NO) production, through increased activity of
endothelial nitric oxide synthase, and hypoxia are sug-
gested to be key stimuli that contribute to the mobilisa-
tion of cEPCs with exercise [33, 9]. However, in some
instances oxidative stress can reduce NO availability,
which could, speculatively, attenuate the signal for
cEPCs mobilisation. Recent research has shown that well
controlled Type 1 diabetes patients demonstrate in-
creased oxidative stress during aerobic exercise, in com-
parison with non-diabetic control participants [34].
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pressive effect of TNF-α in these responses. Future re-
search should examine the role of both oxidative stress
and inflammatory signalling in the acute cEPCs response
to exercise.
Although this study is limited by a relatively small sample
size, it is important to consider the homogenous group that
were observed, with patients all male, aged 19–34 years,
HbA1c range of 6–7.9 %, and all physically fit; as such, the
importance of these data should not be underestimated. Fu-
ture research should explore how improving HbA1c inde-
pendently of improving physical fitness influences markers
of vascular repair at rest and in response to exercise.
Conversely, it would be of interest to explore if improving
physical fitness can rescue the deleterious effect of poor gly-
caemic control on cEPCs regulation. Furthermore, the role
of the insulin species patients are treated with could be an
additional factor to consider when examining the impact of
exercise on cEPCs in this population [35].
Conclusions
In conclusion, Type 1 diabetes patients with high cardio-
respiratory fitness and excellent glycemic control present
normal resting markers of vascular repair (cEPC’s) and in-
jury (cECs), despite being in a persistent inflammatory
state (raised TNF-α). However, the cEPCs response to
acute exercise appears blunted, potentially limiting the
cardiovascular benefits of exercise.
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